ArticleHepatology (Baltimore, Md.)2018

Liver Angiopoietin-2 Is a Key Predictor of De Novo or Recurrent Hepatocellular Cancer After Hepatitis C Virus Direct-Acting Antivirals.

Francesca Faillaci et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.